FindTrial
Sign In

Patient family support in remote warfarin management based on the Alfalfa APP

Patient family support in remote warfarin management based on the Alfalfa APP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113144
Enrollment
Unknown
Registered
2025-11-25
Start date
2025-12-02
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thromboprophylaxis with warfarin, including patients with mitral valve replacement and aortic valve replacement

Interventions

Patient Self-Management Group:None
Patient Relatives Management Group:None

Sponsors

Fujian Maternity and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients enrolled in the Alfalfa APP; 2.Detailed information on the patient's basic medical history and treatment process; 3.Purpose of medication, dosage and medication regimen are clear.

Exclusion criteria

Exclusion criteria: 1.Incomplete information on patient medication; 2.Patients who have not performed a self-upload report;

Design outcomes

Primary

MeasureTime frame
Thromboembolic event rate;Time in therapeutic range;—

Countries

China

Contacts

Public ContactJinhua Zhang

Fujian Maternity and Child Health Hospital

pollyzhang2006@126.com+86 591 88312052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026